Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cet article présente les recommandations de l'"European Society for Medical Oncology" concernant le diagnostic et le traitement d'une leucémie aiguë myéloblastique ainsi que le suivi médical des patients
The yearly incidence of acute myeloblastic leukaemia (AML) in European adults is five to eight cases per 100 000 individuals with a steep increase in the population aged over 70 years where the incidence reaches 15–25/100 000 per annum. The yearly mortality figure in AML is four to six cases per 100 000...
Annals of Oncology , résumé, 2013